Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.
Aronow
W S
WS
Hebrew Hospital Home, Bronx, New York.
Ahn
C
C
Mercando
A D
AD
Epstein
S
S
Kronzon
I
I
D000368:Aged; D000369:Aged, 80 and over; D005117:Cardiac Complexes, Premature / Q000517:prevention & control; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004452:Echocardiography; D015716:Electrocardiography, Ambulatory; D005260:Female; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*; D011446:Prospective Studies; D013318:Stroke Volume; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000517:prevention & control
D011433:Propranolol